Team:Virtus-Parva Mexico/Safety
From 2014.igem.org
(18 intermediate revisions not shown) | |||
Line 54: | Line 54: | ||
<!-- Block of content 1 --> | <!-- Block of content 1 --> | ||
<table width="100%" cellspacing="0" height="500px" border="0"> | <table width="100%" cellspacing="0" height="500px" border="0"> | ||
- | <tr><td bgColor="# | + | <tr><td bgColor="#8AAA3D"></td> |
- | <td width="975px" align="left" bgColor="# | + | <td width="975px" align="left" bgColor="#8AAA3D" > |
<table width="975px" cellspacing="0" height="500px" border="0"> | <table width="975px" cellspacing="0" height="500px" border="0"> | ||
<tr> | <tr> | ||
- | <td width="95%" bgColor="# | + | <td width="95%" bgColor="#8AAA3D" rowspan="3" align="left"> |
Line 72: | Line 72: | ||
</td> | </td> | ||
<!-- This is the back to top button --> | <!-- This is the back to top button --> | ||
- | <td bgColor=# | + | <td bgColor=#8AAA3D> </td> |
- | <tr><td bgColor=# | + | <tr><td bgColor=#8AAA3D></td></tr> |
- | <tr> <td height=" | + | <tr> <td height="50px" width="5%" align="center" bgColor=#8AAA3D> |
- | <a href="#menu" style="text-decoration:none;color:#1C140D"> | + | <a href="#menu" style="text-decoration:none;color:#1C140D"><img src="https://static.igem.org/mediawiki/2014/3/39/Virtus_Parva-TOP-v2.jpg"></img></a> </td></tr> |
</table> | </table> | ||
</td> | </td> | ||
- | <td bgColor="# | + | <td bgColor="#8AAA3D"></td> |
</tr> | </tr> | ||
</table> | </table> | ||
Line 97: | Line 97: | ||
<br> | <br> | ||
<p align="justify"><font size=4 color="#ffffff"> | <p align="justify"><font size=4 color="#ffffff"> | ||
- | Question 1: Would any of your project idea raise safety issues in terms of research safety, public safety or environmental safety? | + | <i>Question 1: Would any of your project idea raise safety <br> |
+ | issues in terms of research safety, public safety or <br> | ||
+ | environmental safety?</i><br> | ||
<br> | <br> | ||
- | The strain of E. Coli we chose to work with, DSM 1103 is considered within Biosafety level 1 and as such is considered an agent with minimal potential hazard to laboratory personnel and the environment. In any case an outbreak were to happen, our E. Coli strain doesn’t contain genes with toxin or antibiotic resistance. In case of contact with eyes or mouth, E. Coli can cause infections and as such we use wear gloves when dealing with our bacteria and dispose them in red safety bags a company will then sterilize before throwing them away. | + | The strain of E. Coli we chose to work with, DSM <br> |
+ | 1103 is considered within Biosafety level 1 and as<br> | ||
+ | such is considered an agent with minimal potential<br> | ||
+ | hazard to laboratory personnel and the environment.<br> | ||
+ | In any case an outbreak were to happen, our E. Coli<br> | ||
+ | strain doesn’t contain genes with toxin or antibiotic<br> | ||
+ | resistance. In case of contact with eyes or mouth, E.<br> | ||
+ | Coli can cause infections and as such we use wear <br> | ||
+ | gloves when dealing with our bacteria and dispose <br> | ||
+ | them in red safety bags a company will then sterilize<br> | ||
+ | before throwing them away. | ||
<br> | <br> | ||
<br> | <br> | ||
- | Question 2: Are any parts or devices in our project associated with (or known to cause) pathogenicity, infectivity, toxicity, threats to environmental quality or security concerns? | + | <i>Question 2: Are any parts or devices in our project <br> |
- | <br> | + | associated with (or known to cause) pathogenicity, <br> |
- | The biggest risk comes from E. Coli infections to our team handling bacteria, an issue for which we have taken precautions. There are no other infectivity, toxicity of pathogenicity threats from our project. Security concerns are very low, as there are minimal security risks. Materials used are very common in microbiology labs and cannot be used maliciously or weaponized. | + | infectivity, toxicity, threats to environmental quality<br> |
+ | or security concerns?</i> | ||
+ | <br><br> | ||
+ | The biggest risk comes from E. Coli infections to our <br> | ||
+ | team handling bacteria, an issue for which we have <br> | ||
+ | taken precautions. There are no other infectivity, <br> | ||
+ | toxicity of pathogenicity threats from our project.<br> | ||
+ | Security concerns are very low, as there are minimal<br> | ||
+ | security risks. Materials used are very common in <br> | ||
+ | microbiology labs and cannot be used maliciously or <br> | ||
+ | weaponized. | ||
<br> | <br> | ||
<br> | <br> | ||
Line 111: | Line 133: | ||
</td> | </td> | ||
- | <td><img src="https://static.igem.org/mediawiki/2014/e/ea/Virtus_Parva_Abraham_saftey.jpg"/></td><td width="162px" bgColor="#355079"></td></tr></table | + | <td bgColor="#355079"><img src="https://static.igem.org/mediawiki/2014/e/ea/Virtus_Parva_Abraham_saftey.jpg"/></td><td width="162px" bgColor="#355079"></td></tr></table> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
Line 151: | Line 157: | ||
- | <p> <font size=4> Question 3: Do any of the new BioBricks parts (or devices) that you made this year raise any safety issues? | + | <p> <font size=4><font color=#FFFFFF><i> Question 3: Do any of the new BioBricks parts (or devices) that you made this year raise any safety issues?</i> |
<br> | <br> | ||
We do not use any BioBricks parts this year, we have designed a device that only affects bacterial systems. | We do not use any BioBricks parts this year, we have designed a device that only affects bacterial systems. | ||
Line 164: | Line 170: | ||
<td bgColor=#8AAA3D </td> | <td bgColor=#8AAA3D </td> | ||
<tr><td bgColor=#8AAA3D></td></tr> | <tr><td bgColor=#8AAA3D></td></tr> | ||
- | <tr> <td height=" | + | <tr> <td height="50px" width="5%" align="center" bgColor=#8AAA3D> |
- | <a href="# | + | <a href="#menu" style="text-decoration:none;color:#1C140D"><img src="https://static.igem.org/mediawiki/2014/3/39/Virtus_Parva-TOP-v2.jpg"></img></a> </td></tr> |
</table> | </table> | ||
</td> | </td> | ||
Line 178: | Line 184: | ||
<tr><td bgColor=#F45D4C ></td></tr> | <tr><td bgColor=#F45D4C ></td></tr> | ||
<tr> <td height="20px" width="5%" align="center" onMouseOver="this.bgColor='#FFFFFF'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | <tr> <td height="20px" width="5%" align="center" onMouseOver="this.bgColor='#FFFFFF'" onMouseOut="this.bgColor='#A1DBB2'" bgColor=#A1DBB2> | ||
- | <a href="#menu" style="text-decoration:none;color:#1C140D"> | + | <a href="#menu" style="text-decoration:none;color:#1C140D"></a> </td></tr> |
</table> | </table> |
Latest revision as of 03:31, 18 October 2014
Our Questions
Question 1: Would any of your project idea raise safety |
|
|